FDA clears St. Jude trial of electrical-stimulation device for depression

02/8/2008 | Star Tribune (Minneapolis-St. Paul, Minn.)

St. Jude Medical has received an investigational-device exemption from the FDA to conduct a clinical trial for its libra deep-brain stimulation system designed to treat severe depression. Neuronetics and Northstar Neuroscience are also exploring electrical stimulation as a treatment for depression.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA